NCT03343925View on ClinicalTrials.gov

Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings

CompletedOBSERVATIONAL

Enrollment

140

Participants

Timeline

Start Date

August 17, 2018

Primary Completion Date

July 1, 2021

Study Completion Date

April 11, 2022

Conditions

Hepatitis C, Chronic

Trial Locations (4)

2010

St Vincent's Hospital, Darlinghurst

2300

Drug and Alcohol Services (Hunter), Newcastle

2751

Nepean Hospital, Kingswood

5000

Infectious Diseases Clinic, Royal Adelaide Hospital, Adelaide

Sponsors

Lead Sponsor

Kirby Institute

All Listed Sponsors

lead

Kirby Institute

OTHER_GOV

NCT03343925 - Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings | Biotech Hunter | Biotech Hunter